LB Pharmaceuticals Inc. announced the appointment of Dr. Minako Pazdera as General Counsel. Dr. Pazdera joins LB Pharmaceuticals with more than 25 years of experience spanning corporate governance, intellectual property, strategic corporate transactions and compliance. Before joining LB Pharmaceuticals, Dr. Pazdera served as General Counsel and Corporate Secretary at Kardigan.
Previously, she was General Counsel and Corporate Secretary at Carmot Therapeutics where she led the legal function during its dual track IPO/strategic transaction process, resulting in the acquisition of Carmot by Roche for up to $3.1 billion in 2024. Her earlier roles encompassed both strategic and intellectual property functions at Lyell Immunopharma, Sangamo Therapeutics and Genentech, as well as in private practice. Dr. Pazdera holds a J.D. from the Fordham University School of Law, a Ph.D. in Biological Sciences from Carnegie Mellon University, and a B.A. in Molecular and Cell Biology from the University of California, Berkeley.
